Catalyst Pharmaceutical Partners shares owned by Ing Investment Management
Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Ing Investment Management
from 13F filings
Historical chart of Ing Investment Management investment in Catalyst Pharmaceutical Partners
Tip: Access up to 7 years of quarterly data
All positions including Catalyst Pharmaceutical Partners held by Ing Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Catalyst Pharmaceutical Partners by Ing Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $8.8M | 446k | 19.70 |
| 2025-06-30 | $7.7M | 357k | 21.70 |
| 2025-03-31 | $1.5M | 62k | 24.25 |
| 2024-12-31 | $1.1M | 52k | 20.87 |
| 2024-09-30 | $834k | 42k | 19.88 |
| 2024-06-30 | $602k | 39k | 15.49 |
| 2024-03-31 | $541k | 34k | 15.94 |
| 2023-12-31 | $671k | 40k | 16.81 |
| 2023-09-30 | $461k | 39k | 11.69 |
| 2023-06-30 | $3.7M | 275k | 13.44 |
| 2023-03-31 | $737k | 44k | 16.58 |
| 2022-12-31 | $1.0M | 56k | 18.60 |
| 2022-09-30 | $756k | 59k | 12.84 |
| 2022-06-30 | $263k | 38k | 7.02 |
| 2022-03-31 | $321k | 39k | 8.28 |
| 2021-12-31 | $262k | 39k | 6.76 |
| 2021-09-30 | $210k | 40k | 5.29 |
| 2021-06-30 | $228k | 40k | 5.75 |
| 2021-03-31 | $210k | 46k | 4.61 |
| 2020-12-31 | $142k | 43k | 3.34 |
| 2020-09-30 | $99k | 33k | 2.96 |
| 2020-06-30 | $154k | 33k | 4.61 |
| 2020-03-31 | $186k | 48k | 3.86 |
| 2019-12-31 | $181k | 48k | 3.75 |
| 2019-09-30 | $207k | 39k | 5.30 |
| 2019-06-30 | $150k | 39k | 3.84 |
| 2019-03-31 | $210k | 41k | 5.10 |
| 2018-12-31 | $79k | 41k | 1.92 |
| 2018-09-30 | $156k | 41k | 3.79 |
| 2018-06-30 | $128k | 41k | 3.11 |
| 2018-03-31 | $79k | 33k | 2.40 |
| 2017-12-31 | $129k | 33k | 3.91 |
| 2017-09-30 | $83k | 33k | 2.52 |
| 2017-06-30 | $91k | 33k | 2.76 |
| 2016-03-31 | $50k | 43k | 1.18 |
| 2015-12-31 | $104k | 43k | 2.45 |
| 2015-09-30 | $127k | 43k | 2.99 |
| 2015-06-30 | $176k | 43k | 4.14 |
Top funds holding Catalyst Pharmaceutical Partners
View all funds holding Catalyst Pharmaceutical Partners